SAN JOSE, Calif., March 26, 2018 -- The latest market report published by Credence Research, Inc. “Medical Bionics Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global medical bionics market was valued at US$ 16,538.9 Mn in 2017, and is expected to reach US$ 36,818.2 Mn by 2026 expanding at a CAGR of 9.22% from 2018 to 2026.
Market Insights
As per the research citing of World Health Organization (2014), the number of deaths due to chronic diseases is 31 million worldwide. Pharmaceutical and biotechnology industries are currently engaged in the development of novel treatment options such as nanobionics and nanobiomimetics to replace conventional methods for the treatment of chronic diseases. The challenges encountered in the neural bionics are the development of a two-way interface in the neural circuits and distributed system architectures. Medical device manufacturers are currently emphasizing on understanding the principles and mechanism that govern the nature of several species in order to develop novel medical bionics.
Heart bionics is the leading market in products segment as a result of growing prevalence of cardiac complications such as valvular stenosis and congenital heart disease. Ear bionics is set to register a significant growth over the forecast period due to rising prevalence of conductive hearing loss related to otitis media infection and otosclerosis. Implantable medical bionics currently dominate the application market on account of the increasing demand for minimal invasive and long term therapy offered with enhanced biocompatibility, mechanical stability and corrosion resistance. External bionics will be the fastest growing market attributed to the increasing number of accidents leading to limb amputations.
Rising prevalence of chronic diseases and increasing demand for noninvasive surgical procedures contribute to the dominance of North America in medical bionics market. Technological advancement in the design and function of medical bionics by the key players have a positive influence on the medical bionics market of North America. Emergence of local players manufacturing medical bionics has created competitive market for medical bionics in Asia Pacific. Supportive regulatory environment for the approval of products in Asia Pacific drives its medical bionics market.
The market leaders of medical bionics market are Boston Scientific Corporation, BionX Medical Technologies, Inc., Cochlear Ltd., Edward Lifesciences Corporation, Ekso Bionics, LifeNet Health Inc., Medtronic Plc., Ossur, Second Sight Medical Products, Inc., and St. Jude Medical, Inc.
Key Market Movements:
- Increasing investment in the R&D segment of medical device manufacturers to develop novel medical bionic devices for treatment of chronic ailments
- Supportive regulatory environment for medical bionic products
- Technological advancement in the integral circuit design of the implantable devices to drive the medical bionics market during the forecast period
Browse Full Report With TOC, Figures And Tables @ http://www.credenceresearch.com/report/medical-bionics-market
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
E-mail: [email protected]
Ph: 1-800-361-8290
Web: Credence Research
Read Our Blog: http://www.mobilecomputingtoday.co.uk/7534/medical-bionics-market-expected-reach-36818-2-2026-credence-research/


Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 



